Intramuscular injection
A method of installing medications into the depth of the bulk of specifically
selected muscles.
Administered at 90-degree angle with a 22 to 25 gauge, ½ -to-1inch needle.
Dosage form: Parenteral
Bioavailability: 75≤100%
Examples:
Antibiotics- Penicillin G benzathine, Streptomycin
Biologicals- Immunoglobins, vaccines, and toxoids
Hormonal agents- Testosterone, medroxyprogesterone
Any drugs that are nonirritant and soluble may be given IM during an emergency
scenario.
Advantage and disadvantages
ADVANTAGES DISADVANTAGES
Rapid and uniform absorption of Expert and a trained person are
the drug, especially those of the required for administrating the
aqueous solutions. drug by IM route.
Rapid onset of the action The absorption of the drug is
compared to that of the oral and determined by the bulk of the
the subcutaneous routes. muscle and its vascularity.
IM injection bypasses the first-pass The onset and duration of the
metabolism. action of the drug is not adjustable.
It also avoids the gastric factors In case of inadvertent scenarios
governing the drug absorption. such as anaphylaxis or
neurovascular injuries,
Has efficacy and potency
intravenous (IV) assess needs to be
comparable to that of the
secured.
intravenous drug delivery system.
IM injection at the appropriate
Highly efficacious in emergency
landmarks may be difficult in a
scenarios such as acute psychosis
child as well as in patients
and status epilepticus.
requiring physical restrain.
Depot injections allow slow, Inadvertent injection in the
sustained, and prolonged action. subcutaneous plane of the fascia
can lead to delayed action of the
A large volume of the drug can be
drug.
administered compared to that of
the subcutaneous route. Painful procedure.
Suspensions, as well as oily drugs,
cannot be administered.
Can lead to anxiety in the patient,
especially in children.
Self-administration of the drug can
be difficult.
The precipitation of the drug
following faster absorption of the
solvent may lead to delayed and
prolonged action of the drug.
Unintended prolonged sequelae
following delayed drug release
from the muscular compartment.
Need for temporary restraint of
the patients, especially in cases
with children.
References:
Bioavailability of Drugs. (2011, September 4). HowMed. Retrieved September 10, 2021
from http://howmed.net/pharmacology/bioavailability-of-drugs/
Gutierrez, J. J. P., & Munakomi, S. (2021). Intramuscular Injection. In StatPearls
[Internet]. StatPearls Publishing. Retrieved September 10, 2021 from
https://www.ncbi.nlm.nih.gov/books/NBK556121/